Clinical Trial: A Study to Test the Safety and Blood Levels of PMG1016 in Healthy Adults

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07615985) titled 'A Study to Test the Safety and Blood Levels of PMG1016 in Healthy Adults' on May 10.

Brief Summary: This study is a first-in-human (FIH), randomized, double-blind, placebo-controlled study of PMG1016 in healthy adult participants. It aims to investigate the safety, tolerability, PK, and immunogenicity of PMG1016 administered via IV infusion.

Cohort 1: Healthy participants receiving single doses of PMG1016 Dose 1 or placebo.

Cohort 2: Healthy participants receiving single doses of PMG1016 Dose 2 or placebo.

Cohort 3: Healthy participants receiving single doses of PMG1016 Dose 3 or placebo.

Cohort 4: Healthy participants receiving ...